Differential effects of transforming growth factor-beta 1 on interleukin-1-induced cellular inflammation and vascular permeability in the rabbit retina

被引:17
作者
Cuff, CA
Martiney, JA
Berman, JW
Brosnan, CF
机构
[1] PICOWER INST MED RES,MANHASSET,NY 11030
[2] ALBERT EINSTEIN COLL MED,DEPT PATHOL,BRONX,NY 10461
[3] ALBERT EINSTEIN COLL MED,DEPT MICROBIOL & IMMUNOL,BRONX,NY 10461
[4] ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10461
关键词
interleukin-1; transforming growth factor beta; inflammation; blood-retina barrier; vascular permeability; rabbit;
D O I
10.1016/S0165-5728(96)00103-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Intra-vitreal injection of 300 U of interleukin (IL)-1 beta into the rabbit eye induces an inflammation of the retina characterized by hemorrhage, monocyte and neutrophil infiltration, and an increase in vascular permeability that peaks 24 h post-injection. Since the epiretinal vessels involved in this inflammation form part of the blood-retina barrier, we used this model to investigate the effects of the immunosuppressive cytokine TGF beta 1 on inflammation within the context of the central nervous system. We found that intra-vitreal injection of 1 mu g rh TGF beta administered concomitantly with rh IL-1 beta significantly reduced IL-1 beta-induced hemorrhage by 78%, and monocyte and neutrophil infiltration by 53% and 62%, respectively. In contrast, TGF beta did not reduce the IL-1 beta-induced increase in vascular permeability. However, TGF beta by itself caused a statistically significant increase in serum proteins in perfused tissues of the eye, to give a 3.1 +/- 0.4 fold increase in protein content over control values. No cellular inflammation accompanied this alteration in vascular permeability. These data indicate that whereas the local administration of TGF beta may be an effective inhibitor of cellular inflammation in the CNS, the effects on alterations in vascular permeability and accumulation of serum proteins may be more complex.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [1] BECK DW, 1980, SCIENCE, V207, P653
  • [2] BOGDAN C, 1992, J BIOL CHEM, V267, P23301
  • [3] TRANSFORMING GROWTH-FACTOR BETA-1 SUPPRESSES ACUTE AND CHRONIC ARTHRITIS IN EXPERIMENTAL-ANIMALS
    BRANDES, ME
    ALLEN, JB
    OGAWA, Y
    WAHL, SM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) : 1108 - 1113
  • [4] TRANSFORMING GROWTH-FACTOR-BETA REGULATES THE ADHESIVE INTERACTIONS BETWEEN MONONUCLEAR-CELLS AND MICROVASCULAR ENDOTHELIUM
    CAI, JP
    FALANGA, V
    CHIN, YH
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (02) : 169 - 174
  • [5] CUFF CA, 1996, IN PRESS GLIA
  • [6] THE INTERLEUKIN-1 FAMILY - 10 YEARS OF DISCOVERY
    DINARELLO, CA
    [J]. FASEB JOURNAL, 1994, 8 (15) : 1314 - 1325
  • [7] DING AH, 1988, J IMMUNOL, V141, P2407
  • [8] TRANSFORMING GROWTH-FACTOR-BETA IS A POTENT INHIBITOR OF INTERLEUKIN-1 (IL-1) RECEPTOR EXPRESSION - PROPOSED MECHANISM OF INHIBITION OF IL-1 ACTION
    DUBOIS, CM
    RUSCETTI, FW
    PALASZYNSKI, EW
    FALK, LA
    OPPENHEIM, JJ
    KELLER, JR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (03) : 737 - 744
  • [9] INHIBITION OF CYTOKINE PRODUCTION BY CYCLOSPORINE-A AND TRANSFORMING GROWTH-FACTOR-BETA
    ESPEVIK, T
    FIGARI, IS
    SHALABY, MR
    LACKIDES, GA
    LEWIS, GD
    SHEPARD, HM
    PALLADINO, MA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (02) : 571 - 576
  • [10] NERVOUS-TISSUE AS AN IMMUNE COMPARTMENT - THE DIALECT OF THE IMMUNE-RESPONSE IN THE CNS
    FABRY, Z
    RAINE, CS
    HART, MN
    [J]. IMMUNOLOGY TODAY, 1994, 15 (05): : 218 - 224